检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:赵蜀琪 韩正学[1] ZHAO Shuqi;HAN Zhengxue(Department of Oral and Maxillofacial-Head and Neck Oncology,Capital Medical University School of Stomatology,Beijing,100050,China)
机构地区:[1]首都医科大学口腔医学院口腔颌面-头颈肿瘤科,北京100050
出 处:《临床耳鼻咽喉头颈外科杂志》2023年第9期740-747,共8页Journal of Clinical Otorhinolaryngology Head And Neck Surgery
摘 要:全球范围内口咽癌的新发患者正逐年增加,HPV感染是导致此类恶性肿瘤的危险因素。相较于HPV阴性的口咽癌,HPV阳性患者对放化疗更加敏感,且具有更好的预后,但目前并没有针对于HPV阳性患者公认的治疗方案。适当降低HPV阳性口咽癌的治疗强度,探索最佳的治疗方案以减少治疗的毒副反应,是亟待解决的临床问题。本文就近年来HPV阳性口咽癌患者治疗方法改进的研究进展进行综述。The number of new cases of oropharyngeal cancer is increasing year by year among the world,and HPV infection is one of the risk factors for this malignant tumor.Compared with HPV-negative oropharyngeal cancer,HPV-positive patients are more sensitive to radiotherapy and have a better prognosis,but there is no accepted treatment for HPV-positive patients.Reducing treatment intensity moderately and exploring the best option to minimize side effects of treatment are urgent issues to be addressed.This article reviews the research progress on the treatment improvement of HPV-associated oropharyngeal cancer in recent years.
分 类 号:R766.4[医药卫生—耳鼻咽喉科]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.130